Speaker illustration

Doctor Henrik Sillesen

Novo Nordisk Foundation, Copenhagen (Denmark)

Member of:

European Society of Cardiology

Henrik Sillesen is Head of dept. and Professor of vascular surgery, Dept. of Vascular Surgery, Rigshospitalet, Univ. of Copenhagen, Denmark Doctorate of Medical Science (DMSc), Univ. of Copenhagen, 1990 He has authoered 237 peer-review, published papers (pubmed) and given > 250 invited lectures at international meetings in 34 countries. H-index is 44 and number of citations > 11.000 (Web of Science). Henrik Sillesen has supervised 14 doctorial thesis (DMSc) or PhD degrees. Henrik Sillesen has served on the editorial board of Ultrasound in Medicine and Biology and Eur J Vasc Endovasc Surg and has been Guest Editor Journal of American College Cardiology. Currently, Henrik Sillesen is president for the THE EUROPEAN SOCIETY OF VASCULAR SURGERY of which he served as Secretary General 2004-9. Served as President for WORLD FEDERATION FOR VASCULAR SPECIALTIES in 2009. President for the DANISH SOCIETY FOR VASCULAR SURGERY 2003-2005 and President for the DANISH HEART FOUNDATION in 2006-2008.

Effects of semaglutide on functional capacity in patients with type 2 diabetes and peripheral arterial disease: rationale and design of the STRIDE trial

Event: ESC Congress 2021 - The Digital Experience

Topic: Pharmacotherapy

Session: Peripheral Vascular and Cerebrovascular Disease ePosters

Thumbnail

A diabetic patient with critical limb ischemia and below-the-knee disease

Event: ESC Congress 2019

Topic: Treatment

Session: Lower extremity artery disease: when to revascularise?

Thumbnail

Management of abdominal aorta aneurysms.

Event: ESC Congress 2019

Topic: Treatment

Session: Aneurysms: optimal management in 2019

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb